Tomas J. Philipson: Chicago’s housing market shouldn’t have a hidden inventory September 6, 2026 at 5:00 a.m. A dominant housing market gatekeeper should not be able to use its control over market information to leave consumers with fewer choices.
Tomas J. Philipson: Price controls on medicines are stymieing innovation. Trump’s plan will make it worse. May 20, 2026 at 5:00 a.m. Proponents of price controls are wagering that savings on medicines will outweigh the lost benefits. The opposite is true.
Tomas J. Philipson: Donald Trump’s drug-pricing pressure is working — but it requires nuance November 7, 2025 at 5:00 a.m. Drugmakers feel empowered to resist foreign price controls — confident that the Trump administration will have their backs.
Tomas J. Philipson: How Donald Trump can safeguard our drug supply September 4, 2025 at 5:00 a.m. In the event of a conflict, or even just trade tensions, China could restrict drug exports and threaten hundreds of thousands of American patients.
Tomas Philipson: By avoiding funding Alzheimer’s research, the government is cutting seniors’ life spans May 18, 2023 at 10:59 a.m. Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer's medication appears to slow cognitive decline by 35%....